Cambium Bio Competitors and Similar CompaniesClear all
Cambium Bio's competitors and similar companies include BBI Life Sciences.
 Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. | ||
Founding Date | Founding Date 2007 | Founding Date 2013 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Paddington, AU HQ Pymble, AU | Locations CN HQ |
Employees | Employees N/A | Employees 1,588 |
Financial | ||
Revenue (est.) | Revenue (est.) $670k (FY, 2025) | Revenue (est.) ¥703.8m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods ¥288m (FY, 2019) |
Gross profit | Gross profit $1.2m (FY, 2025) | Gross profit ¥417.2m (FY, 2019) |
Net income | Net income ($3.8m) (FY, 2025) | Net income ¥86m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
BBI Life Sciences
HQ
CN
Employees
1,588
BBI Life Sciences (BBI生命科学) is a supplier of life science products and services.
View company